Search
for
Sort by
Research 181–210 of 1000+
- Hair and scalp dermatoscopy
- Cutaneous adverse effects of targeted therapies
- Cutaneous complications of chemotherapeutic agents
- Quality of life in cutaneous lupus erythematosus
- Primary cicatricial alopecia
- Central centrifugal cicatricial alopecia: Past, present, and future
- Dermatoscopic features of central centrifugal cicatricial alopecia
- Management of patients and side effects during cyclosporine therapy for cutaneous disorders
- Androgens in women
- Alopecia and periorificial dermatitis in biotin-responsive multiple carboxylase deficiency
- Trichodysplasia of immunosuppression treated with oral valganciclovir
- Psychocutaneous disease
- Hair transplantation: Basic overview
- White piedra: further evidence of a synergistic infection
- Lymphomatoid granulomatosis
- Iron deficiency and hair loss: The jury is still out
- Practical contact dermatitis
- Pityriasis rubra pilaris: A study evaluating patient quality of life in 2 populations
- Summation and recommendations for the safe and effective use of topical and oral minoxidil
- Platelet-rich plasma lacks evidence of clinically significant improvement in androgenetic alopecia
- HIV and alopecia universalis
- Response to Corona-Rodarte et al.’s “Pressure alopecias: a review”
- Biotin beware: Perils of biotin supplementation: Response to: “The epidemiology, impact, and diagnosis of micronutrient nutritional dermatoses. Part 2: B-complex vitamins”
- Melanotic pigmentation in excisional scar of melanoma patient who received BRAF and MEK inhibitors
- Acneiform eruptions caused by an epidermal growth factor receptor-tyrosine kinase inhibitor ZD 1839
- Bald scalps and wrinkles
- 50524 Facebook groups provide support and product recommendations for patients using scalp cooling to prevent chemotherapy-induced alopecia: A survey study
- Evaluating subjective versus objective measures of changes in hair density using standardized scalp photography
- 41126 Analysis of Nail Excision Practice Patterns in the Medicare Provider Utilization and Payment Database 2012-2017
- Reply to early onset effluvium secondary to COVID-19 and body-hair effluvium